Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea
Status:
Completed
Trial end date:
2016-03-16
Target enrollment:
Participant gender:
Summary
The investigators propose that the sustained administration of a vaginal ring would have a
better response with respect to pain and a better safety profile than the oral administration
of a non-steroidal anti-inflammatory drug.
To assess the relief of the symptoms associated with dysmenorrhea, a specific survey was
elaborated that also includes a Visual Analog Scale (VAS) to objectify and measure
dysmenorrhea as is the case with McGill's Pain Questionnaire (MPQ).